A mobile app to detect absence seizures using breathing and eye movements
A Mobile Health Application to Detect Absence Seizures using Hyperventilation and Eye-Movement Recordings
This study is testing a new mobile app designed to help people with absence epilepsy track their condition and see how well their treatments are working, making it easier for them to manage their health from home.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Eysz, INC. NIH-funded |
| Lab location | 1 site (Berkeley, UNITED STATES) |
| Project ID | NIH-10696649 on NIH RePORTER |
What this research studies
This research focuses on developing a mobile health application that helps diagnose and monitor absence epilepsy remotely. The app will utilize guided hyperventilation and record eye movement and facial biometric data to assess seizure susceptibility and treatment responses. This approach aims to provide a more accessible and accurate method for patients to track their condition outside of clinical settings, addressing the limitations of traditional diagnostic methods like video EEG. By leveraging technology, the app seeks to improve the accuracy of absence seizure detection and enhance patient care.
Who could benefit from this research
Good fit: Ideal candidates for this research are children and young adults aged 0-21 who experience absence seizures.
Not a fit: Patients with seizure types other than absence seizures may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and timely diagnosis and monitoring of absence seizures, improving treatment outcomes for patients.
How similar studies have performed: While the use of mobile health applications for seizure monitoring is emerging, this specific approach using hyperventilation and biometric data is relatively novel and has not been extensively tested.
Where this research is happening
Berkeley, UNITED STATES
- Eysz, INC. — Berkeley, United States (Active)
Researchers
- Principal investigator: Kuperman, Rachel — Eysz, INC.
- Study coordinator: Kuperman, Rachel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.